According to two Indian government officials, the country will probably relax some export restrictions on pharmaceutical products soon due to pressure from the US, which is worried about drug shortages amid the COVID-19 pandemic, as reported Wednesday in U.S. News & World.
The officials said an easing of those restrictions will probably come within two days and will likely include paracetamol, also known as acetaminophen.
"There is so much (US) pressure on the government. For the US, what matters is paracetamol, it matters to them significantly," said one official, adding that India had adequate stock of the drug for domestic use for at least four months.
Last month, India restricted exports of 26 pharmaceutical ingredients and the medicines made from them, in an attempt to secure supplies for its domestic population after the coronavirus outbreak hit the industry's supply chain globally.
According to the news source, the Indian officials said the restrictions will be lifted for all countries, but it was not immediately clear exactly how many drug formulations would be exempted.
To read more NewsPoints articles, click here.